FR2687574B1 - Nouvelle application therapeutique de derives du pyridylpyrrolothiazole carboxamide. - Google Patents

Nouvelle application therapeutique de derives du pyridylpyrrolothiazole carboxamide.

Info

Publication number
FR2687574B1
FR2687574B1 FR9202156A FR9202156A FR2687574B1 FR 2687574 B1 FR2687574 B1 FR 2687574B1 FR 9202156 A FR9202156 A FR 9202156A FR 9202156 A FR9202156 A FR 9202156A FR 2687574 B1 FR2687574 B1 FR 2687574B1
Authority
FR
France
Prior art keywords
pyridylpyrrolothiazole
new therapeutic
therapeutic application
carboxamide derivatives
carboxamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9202156A
Other languages
English (en)
Other versions
FR2687574A1 (fr
Inventor
Anna Bousseau
Daniel Lave
Francoise Soler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Priority to FR9202156A priority Critical patent/FR2687574B1/fr
Priority to MX9300899A priority patent/MX9300899A/es
Priority to CA002127545A priority patent/CA2127545A1/fr
Priority to EP93905414A priority patent/EP0628047A1/fr
Priority to JP5514591A priority patent/JPH07503966A/ja
Priority to PCT/FR1993/000173 priority patent/WO1993017027A1/fr
Publication of FR2687574A1 publication Critical patent/FR2687574A1/fr
Application granted granted Critical
Publication of FR2687574B1 publication Critical patent/FR2687574B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FR9202156A 1992-02-25 1992-02-25 Nouvelle application therapeutique de derives du pyridylpyrrolothiazole carboxamide. Expired - Fee Related FR2687574B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR9202156A FR2687574B1 (fr) 1992-02-25 1992-02-25 Nouvelle application therapeutique de derives du pyridylpyrrolothiazole carboxamide.
MX9300899A MX9300899A (es) 1992-02-25 1993-02-19 Derivados de 3-(3-piridil) 1h,3h-pirrolo[1,2-c]tiazol 7-carboxamida, su aplicacion y procedimiento para la preparcion de una composicion farmaceutica que contiene tal derivado
CA002127545A CA2127545A1 (fr) 1992-02-25 1993-02-22 Nouvelle application therapeutique de derives de pyridylpyrrolothiazole carboxamide
EP93905414A EP0628047A1 (fr) 1992-02-25 1993-02-22 Nouvelle application therapeutique de derives du pyridylpyrrolothiazole carboxamide
JP5514591A JPH07503966A (ja) 1992-02-25 1993-02-22 ピリジルピロロチアゾールカルボキシアミド誘導体の新規な治療的適用
PCT/FR1993/000173 WO1993017027A1 (fr) 1992-02-25 1993-02-22 Nouvelle application therapeutique de derives du pyridylpyrrolothiazole carboxamide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9202156A FR2687574B1 (fr) 1992-02-25 1992-02-25 Nouvelle application therapeutique de derives du pyridylpyrrolothiazole carboxamide.

Publications (2)

Publication Number Publication Date
FR2687574A1 FR2687574A1 (fr) 1993-08-27
FR2687574B1 true FR2687574B1 (fr) 1995-05-05

Family

ID=9427000

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9202156A Expired - Fee Related FR2687574B1 (fr) 1992-02-25 1992-02-25 Nouvelle application therapeutique de derives du pyridylpyrrolothiazole carboxamide.

Country Status (6)

Country Link
EP (1) EP0628047A1 (fr)
JP (1) JPH07503966A (fr)
CA (1) CA2127545A1 (fr)
FR (1) FR2687574B1 (fr)
MX (1) MX9300899A (fr)
WO (1) WO1993017027A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6908923B2 (en) 2001-12-21 2005-06-21 Cytokinetics, Inc. Compositions and methods for treating heart failure
DK2666481T3 (en) 2003-12-26 2019-02-25 Masatoshi Hagiwara A method for regulating the phosphorylation of SR protein and antiviral agents comprising an SR protein activity regulator as the active ingredient
JP7309725B2 (ja) * 2018-08-21 2023-07-18 杏林製薬株式会社 ２環性ヘテロ芳香環誘導体

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601015B1 (fr) * 1986-07-04 1988-08-05 Rhone Poulenc Sante Nouveaux derives du 1h,3h-pyrrolo (1,2-c) thiazole, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2678834A1 (fr) * 1991-07-09 1993-01-15 Rhone Poulenc Rorer Sa Nouvelle application therapeutique du pyridylpyrrolothiazole carboxamide.

Also Published As

Publication number Publication date
WO1993017027A1 (fr) 1993-09-02
EP0628047A1 (fr) 1994-12-14
JPH07503966A (ja) 1995-04-27
CA2127545A1 (fr) 1993-09-02
FR2687574A1 (fr) 1993-08-27
MX9300899A (es) 1993-09-01

Similar Documents

Publication Publication Date Title
DK42093D0 (da) Administrationsmetode
LV11895A (lv) 4-benzoilpirazola atvasinajumi un to pielietojums par herbicidiem
MA23226A1 (fr) Derives optiquement actifs de 2-imidazoline-5-ones et 2-imidazoline-
BR9507179A (pt) Derivados de 3-aril-4-hidróxi-delta3-dihidrotiofena
FI970112A0 (fi) Helico-bakeerin vastaisia atsolonien asyylijohdannaisia
FR2757059B1 (fr) Nouvelle application therapeutique des derives du pyrrole
FI931023A7 (fi) Uusia b-aminohappojohdannaisia
FR2735475B1 (fr) Derives de n-((1,4-diazabicyclo(2.2.2)oct-2-yl)methyl) benzamide, leur preparation et leur application en therapeutique
MA22916A1 (fr) Derives de 2-imidazoline-5-ones et 2-imidazoline-5-thiones fongicides.
FI990399A7 (fi) Karboksiamidijohdannaisia
BR9607046A (pt) Derivados de 3-pirrolidiliden-2-ona-cefalosporinas
FI944280L (fi) Mingreenin vastaisia indolyylialkyyli-pyridinyyli- ja-pyrimidinyyli-piperatsiinien syklobuteenidionijohdannaisia
NO950731D0 (no) Optisk aktive karboksamidderivater
BE893276A (fr) Nouvelle application therapeutique d'un derive de l'acetamide
FR2691359B1 (fr) Nouvelle application therapeutique du malate de 1-citrulline.
EP0804205A4 (fr) Derives de 4-aza-19-norandrostane
NO922522D0 (no) Piperidinylpyrimidin-karboksamidderivater med terapeutiskvirkning
FR2735476B1 (fr) Nouvelle application de derives du pyrrole
PL327059A1 (en) Derivatives of 5-naphtalen-1-yl 1,3-dioxane, their production and therapeutic application
FR2670780B1 (fr) Derives de 4-(acylamino)benzopyranes, leur preparation et leur application en therapeutique.
FI951494A0 (fi) Jyvien käsittely laajentimella
FI944678L (fi) 3,4-dihydro-2H-1-bentsopyraanien hydratsidijohdannaisia
FI935609L (fi) Dihydrofuroimidatsolijohdannaisten asymmetrinen hydraus
NO306861B1 (no) Asymmetrisk hydrogenering av furoimidazol-derivater
FI945956A7 (fi) Furoimidatsolijohdosten asymmetrinen hydraus

Legal Events

Date Code Title Description
ST Notification of lapse